LEXINGTON, Mass.--(BUSINESS WIRE)--Synta Pharmaceuticals Corp. (NASDAQ: SNTA) announced today that it has priced an underwritten public offering of 22,000,000 shares of its common stock at a price to the public of $1.75 per share. Gross proceeds to Synta are expected to be approximately $38.5 million, before deducting the underwriting discounts and commissions and estimated offering expenses payable by Synta. The offering is expected to close on or about April 6, 2015, subject to satisfaction of customary closing conditions. Synta has granted the underwriters a thirty (30) day option to purchase up to 3,300,000 additional shares.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
